Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07266740 · ClinicalTrials.gov registry record · NA

PURSUIT: A Technologically Augmented School-based Program to Improve Child Coping and Prevent Substance Use.

A NA study, sponsored by Michigan State University.

Not yet
Registry status
NA
Development phase
100
Enrollment target

NCT07266740: Clinical Trial NA study, sponsored by Michigan State University.

NCT07266740 is a NA study that has not yet begun recruiting, run by Michigan State University. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07266740, a NA study, has not yet begun recruiting, sponsored by Michigan State University.

NOT YET RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The study investigators aim to test an online support platform for Michigan youth aged 8-18 years enrolled in elementary, middle, or high school and their parent/caregiver. The online support platform will be hosted on the Computerized Intervention Authoring System (CIAS) 3.0 and will provide evidence-based cognitive behavioral coping skills for physical (pain) and mental (stress, mood) health symptoms, with additional substance use prevention content for youth aged 12 and older. Evaluations will occur at baseline and then a post assessment approximately 8 weeks later.

Primary Outcome

The percentage of youth who complete a post-assessment measure, relative to those who complete a baseline assessment.

Interventions

  • BEHAVIORAL PURSUIT

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2026-08-01
Est. Completion 2026-10
Phase NA
Michigan State University

120 total trials

What is known before NCT07266740 opens enrollment

NCT07266740 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which PURSUIT is the first listed.

NCT07266740 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07266740 about?

NCT07266740 is a clinical study titled "PURSUIT: A Technologically Augmented School-based Program to Improve Child Coping and Prevent Substance Use.". The study investigators aim to test an online support platform for Michigan youth aged 8-18 years enrolled in elementary, middle, or high school and their parent/caregiver. The online support platform will be hosted on the Computerized Intervention Authoring System (CIAS) 3.0 and will provide eviden...

What is the current status of trial NCT07266740?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-08-01. Estimated completion is 2026-10.

What interventions are being tested in trial NCT07266740?

The interventions under investigation include: PURSUIT (BEHAVIORAL).

Who is sponsoring clinical trial NCT07266740?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07266740's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07266740, the US trial registry maintained by the National Library of Medicine. NCT07266740 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.